Phathom Pharmaceuticals (PHAT) Insider Trading & Ownership → Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (From Monetary Gold) (Ad) Free PHAT Stock Alerts $10.42 +0.75 (+7.76%) (As of 03:46 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Phathom Pharmaceuticals (NASDAQ:PHAT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$27,540.00Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$30.40 M Get PHAT Insider Trade Alerts Want to know when executives and insiders are buying or selling Phathom Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PHAT Insider Buying and Selling by Quarter Ad InvestorPlaceCrypto Pioneer Says: “The last crypto bull market has begun.”Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… Phathom Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/8/2024Molly HendersonCFOSell3,435$11.10$38,128.50 3/22/2024Terrie CurranInsiderSell16,851$9.11$153,512.61 1/24/2024Pharmaceutical Co Ltd TakedaMajor ShareholderSell3,703,703$8.10$29,999,994.30 1/19/2024Molly HendersonCFOSell6,307$7.75$48,879.25 11/8/2023Asit ParikhDirectorBuy2,500$7.80$19,500.00 11/6/2023Asit ParikhDirectorBuy1,000$8.04$8,040.00 11/1/2023Molly HendersonCFOSell12,492$8.88$110,928.96 6/2/2023Molly HendersonCFOSell1,960$11.41$22,363.60 5/22/2023Molly HendersonCFOSell2,110$12.87$27,155.70 (Data available from 1/1/2013 forward) PHAT Insider Trading Activity - Frequently Asked Questions Who is on Phathom Pharmaceuticals's Insider Roster? The list of insiders at Phathom Pharmaceuticals includes Asit Parikh, Azmi Nabulsi, David A Socks, Molly Henderson, Pharmaceutical Co Ltd Takeda, and Terrie Curran. Learn more on insiders at PHAT. What percentage of Phathom Pharmaceuticals stock is owned by insiders? 24.10% of Phathom Pharmaceuticals stock is owned by insiders. Learn more on PHAT's insider holdings. Which Phathom Pharmaceuticals insiders have been buying company stock? The following insiders have purchased PHAT shares in the last 24 months: Asit Parikh ($108,740.00), Azmi Nabulsi ($245,800.00), and Terrie Curran ($101,026.58). How much insider buying is happening at Phathom Pharmaceuticals? Insiders have purchased a total of 57,419 PHAT shares in the last 24 months for a total of $455,566.58 bought. Which Phathom Pharmaceuticals insiders have been selling company stock? The following insiders have sold PHAT shares in the last 24 months: Molly Henderson ($289,790.50), Pharmaceutical Co Ltd Takeda ($29,999,994.30), and Terrie Curran ($213,508.25). How much insider selling is happening at Phathom Pharmaceuticals? Insiders have sold a total of 3,759,586 Phathom Pharmaceuticals shares in the last 24 months for a total of $30,503,293.05 sold. More Insider Trading Tools from MarketBeat Related Companies: IGM Biosciences Insider Selling ArriVent BioPharma Insider Selling Stoke Therapeutics Insider Selling Aerovate Therapeutics Insider Selling Olema Pharmaceuticals Insider Selling Avid Bioservices Insider Selling Zymeworks Insider Selling Lyell Immunopharma Insider Selling Applied Therapeutics Insider Selling ORIC Pharmaceuticals Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:PHAT) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportElon’s New Device is About to Shock the WorldInvestorPlaceAmerica’s worst nightmare?Porter & CompanyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phathom Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.